Investor Highlights

2017 AGM Presentation

Presentation by the Pharmaxis CEO and CFO to the 2017 AGM

Read full ASX announcement – pdf

Chairman's Address to 2017 Annual General Meeting

Chairman's Address by Malcolm McComas to the 2017 Annual General Meeting

Read full ASX announcement – pdf

Shareholder Update - September 2017

Shareholder update for the quarter ended 30 September 2017

Read quarterly update - pdf

Pharmaxis Strengthens Drug Discovery Capability as its Technology Platform Continues to Deliver

  • Head of Chemistry (ex Boehringer Ingelheim) recruited to Drug Discovery leadership team
  • Two leading scientists join Scientific Advisory Board
  • Amine Oxidase chemistry platform delivers five lead candidates in fibrosis and inflammation over four years as Pharmaxis states ambition to expand its drug discovery activities into new technologies and take select programs into phase 2 clinical trials.


Read full media release - pdf